A trial looking at ozekibart (INBRX-109) for people with chondrosarcoma (ChonDRAgon)

This trial is looking at a drug called ozekibart (INBRX-109) for a primary bone cancer called chondrosarcoma. A primary bone cancer is one that started in the bone.

You pronounce ozekibart as ozek-e-bart.

It is open to people with the most common type of chondrosarcoma called conventional chondrosarcoma:

• that has spread to another part of the body or

• cannot be removed by surgery with the aim to cure